MLchartDataset catalogue

XELIRI

Term · Oncology and biomedicine · MLC-T-ONC-009400

An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, CAPIRI regimen, and XELIRI regimen.

Table 1. Record
IdentifierMLC-T-ONC-009400
FieldOncology and biomedicine
ExpansionsCAPIRI regimen; XELIRI regimen
SynonymsCAPIRI
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009400",
  "term": "XELIRI",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, CAPIRI regimen, and XELIRI regimen.",
  "expansions": [
    "CAPIRI regimen",
    "XELIRI regimen"
  ],
  "synonyms": [
    "CAPIRI"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/xeliri/"
}

Record 17,480 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.